Market Place
Sourcing Support
All News #Library
Biotech
Elutia Reports Q4/FY Results, Launches NXT-41 Regulatory Process
11 Mar 2026 //
GLOBENEWSWIRE
Elutia Presents NXT-41x at the Global Bio-Innovation Forum
10 Jan 2026 //
GLOBENEWSWIRE
Elutia Shows Biologic Envelopes Aid CIED Stabilization
16 Sep 2025 //
GLOBENEWSWIRE
Elutia`s Q2 2025 Financial Results to be Reported on August 14
31 Jul 2025 //
GLOBENEWSWIRE
Elutia Publishes Study on Antibiotic-Eluting Biologic Envelope
25 Mar 2025 //
GLOBENEWSWIRE
Elutia Publishes Data On EluPro Antibiotic-Eluting Envelope
18 Sep 2024 //
GLOBENEWSWIRE
Elutia Completes Divestiture of Orthobiologics Business Unit
09 Nov 2023 //
GLOBENEWSWIRE
Elutia Announces Private Placement for Proceeds Up to $26 Million
19 Sep 2023 //
GLOBENEWSWIRE
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds
18 Sep 2023 //
GLOBENEWSWIRE
Aziyo Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
06 Sep 2023 //
GLOBENEWSWIRE
Aziyo Biologics Announces Publication of a CanGaroo® Case Study
30 Aug 2023 //
GLOBENEWSWIRE
Aziyo Biologics Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Aziyo Biologics to Report Second Quarter 2023 Financial Results
31 Jul 2023 //
GLOBENEWSWIRE
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
13 Jul 2023 //
GLOBENEWSWIRE
Aziyo Biologics Presents Positive Clinical Data on CanGaroo Biologic Envelope
19 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
10 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics to Report 1Q 2023 FYR on Wednesday, May 10, 2023
03 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo
20 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.